Skip to main content

Herpes Simplex Labialis News

Herpes Infections Recently Cost $35 Billion Globally

THURSDAY, July 18, 2024 – Herpes simplex virus (HSV)-2 and HSV-1 infections and their consequences cost $35 billion globally in 2016, according to a study published online July 2 in BMC Global and ...

BioAlliance Pharma's Sitavig Receives FDA Approval for the Treatment of Herpes Labialis

Paris, April 15, 2013 – BioAlliance Pharma SA (Euronext Paris - BIO), today announced the receipt of marketing authorization from the U.S. Food and Drug Administration (FDA) for Sitavig in the t...

Ask a question

To post your own question to our community, sign in or create an account.

Further information

Related condition support groups

Herpes Simplex

Related drug support groups

acyclovir, Valtrex, valacyclovir